What is the management for a patient with severe hyponatremia (sodium level of 110 mmol/L)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Severe Hyponatremia (Sodium 110 mmol/L)

Immediate Assessment and Classification

A sodium level of 110 mmol/L represents severe, life-threatening hyponatremia requiring urgent intervention based on symptom severity, not the number alone. 1

Determine Symptom Severity (Dictates Treatment Urgency)

  • Severe symptoms (seizures, coma, altered mental status, cardiorespiratory distress): This is a medical emergency requiring immediate hypertonic saline 1, 2
  • Moderate symptoms (nausea, vomiting, confusion, headache, gait instability): Requires hospital admission with monitored correction 1, 3
  • Mild/asymptomatic: Slower correction is safer, but sodium this low still warrants aggressive workup 1, 4

Assess Volume Status (Dictates Underlying Cause and Treatment)

  • Hypovolemic signs: Orthostatic hypotension, dry mucous membranes, decreased skin turgor, flat neck veins 1
  • Euvolemic: No edema, normal blood pressure, normal skin turgor 1
  • Hypervolemic signs: Peripheral edema, ascites, jugular venous distention, pulmonary congestion 1, 5

Emergency Treatment for Severe Symptomatic Hyponatremia

If the patient has seizures, coma, or severe altered mental status, immediately administer 3% hypertonic saline as 100 mL IV bolus over 10 minutes. 1, 2

  • Target correction: Increase sodium by 4-6 mmol/L over the first 1-6 hours or until severe symptoms resolve 1, 2
  • Repeat boluses: Can give up to three 100 mL boluses at 10-minute intervals if symptoms persist 1
  • Maximum correction limit: Never exceed 8 mmol/L increase in 24 hours (some guidelines allow 10 mmol/L, but 8 mmol/L is safer for chronic hyponatremia) 1, 2, 4
  • Monitoring: Check serum sodium every 2 hours during initial correction phase 1

Critical Safety Point: Osmotic Demyelination Syndrome

  • Overly rapid correction (>8 mmol/L in 24 hours) causes osmotic demyelination syndrome, presenting 2-7 days later with dysarthria, dysphagia, quadriparesis, or locked-in syndrome 1, 2
  • High-risk patients (advanced liver disease, alcoholism, malnutrition, prior encephalopathy, severe hyponatremia <120 mmol/L) require even slower correction at 4-6 mmol/L per day 1, 4

Treatment Based on Volume Status

Hypovolemic Hyponatremia (True Volume Depletion)

Administer isotonic saline (0.9% NaCl) for volume repletion at 15-20 mL/kg/h initially, then 4-14 mL/kg/h based on response. 1, 3

  • Diagnostic clue: Urine sodium <30 mmol/L predicts saline responsiveness with 71-100% positive predictive value 1
  • Causes: Gastrointestinal losses (vomiting, diarrhea), diuretic overuse, burns, third-spacing 1, 5
  • Once euvolemic: Switch to maintenance isotonic fluids at 30 mL/kg/day 1
  • Avoid: Hypotonic fluids (lactated Ringer's, 0.45% saline, D5W) which worsen hyponatremia 1, 6

Euvolemic Hyponatremia (SIADH Most Common)

Fluid restriction to 1 L/day is the cornerstone of treatment for SIADH. 1, 3

  • If no response to fluid restriction: Add oral sodium chloride 100 mEq (approximately 6 grams) three times daily 1
  • For severe symptoms: Use 3% hypertonic saline as described above, then transition to fluid restriction once symptoms resolve 1, 2
  • Second-line pharmacological options:
    • Urea 15-30 grams twice daily (very effective, poor palatability) 1, 4
    • Tolvaptan 15 mg once daily, titrate to 30-60 mg (risk of overly rapid correction, increased thirst) 1, 7, 2
  • Diagnostic criteria for SIADH: Euvolemia, urine osmolality >100 mOsm/kg (typically >300), urine sodium >20-40 mmol/L, normal thyroid/adrenal function 1, 5

Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)

Implement fluid restriction to 1-1.5 L/day and discontinue diuretics temporarily if sodium <125 mmol/L. 1, 3

  • For cirrhotic patients: Consider albumin infusion alongside fluid restriction 1
  • Avoid hypertonic saline unless life-threatening symptoms present, as it worsens fluid overload 1, 6
  • Sodium restriction (not fluid restriction) results in weight loss, as fluid follows sodium 1
  • Vaptans (tolvaptan) may be considered for persistent severe hyponatremia despite fluid restriction, but use with extreme caution in cirrhosis due to higher risk of gastrointestinal bleeding (10% vs 2% placebo) 1, 7

Calculating Sodium Deficit and Correction Rate

Sodium deficit = Desired increase in Na (mEq/L) × (0.5 × ideal body weight in kg) 1

  • Example: For a 70 kg patient with Na 110, to increase by 6 mEq/L: 6 × (0.5 × 70) = 210 mEq sodium needed
  • 3% hypertonic saline contains 513 mEq/L sodium: 210 mEq ÷ 513 = approximately 410 mL over 6 hours
  • After initial 6 mmol/L correction: Only 2 mmol/L additional correction allowed in next 18 hours to stay within 8 mmol/L/24-hour limit 1

Essential Diagnostic Workup (Do Not Delay Treatment)

  • Serum osmolality: Exclude pseudohyponatremia (normal 275-290 mOsm/kg) 1, 5
  • Urine osmolality and urine sodium: Differentiate causes 1, 3
  • Serum glucose: Hyperglycemia causes pseudohyponatremia (add 1.6 mEq/L to sodium for each 100 mg/dL glucose >100) 1
  • TSH and cortisol: Rule out hypothyroidism and adrenal insufficiency 1
  • Serum uric acid: <4 mg/dL suggests SIADH with 73-100% positive predictive value 1

Management of Overcorrection

If sodium correction exceeds 8 mmol/L in 24 hours, immediately discontinue current fluids and switch to D5W (5% dextrose in water). 1, 4

  • Consider desmopressin (2-4 mcg IV/SC) to slow or reverse rapid rise 1
  • Goal: Bring total 24-hour correction back to ≤8 mmol/L from starting point 1
  • Monitor closely: Osmotic demyelination typically occurs 2-7 days after overcorrection 1, 2

Special Populations and Pitfalls

Neurosurgical Patients: Distinguish SIADH from Cerebral Salt Wasting (CSW)

  • CSW requires volume and sodium replacement (isotonic or hypertonic saline), NOT fluid restriction 1
  • CSW characteristics: True hypovolemia (CVP <6 cm H₂O), urine sodium >20 mmol/L despite volume depletion, orthostatic hypotension 1
  • Treatment for CSW: Normal saline 50-100 mL/kg/day, fludrocortisone 0.1-0.2 mg daily for severe symptoms 1
  • Never use fluid restriction in subarachnoid hemorrhage patients at risk of vasospasm 1

Cirrhotic Patients

  • Require more cautious correction (4-6 mmol/L per day, maximum 8 mmol/L in 24 hours) due to higher risk of osmotic demyelination 1, 4
  • Hyponatremia in cirrhosis increases risk of spontaneous bacterial peritonitis (OR 3.40), hepatorenal syndrome (OR 3.45), and hepatic encephalopathy (OR 2.36) 1

Alcoholic Patients

  • Extremely high risk for osmotic demyelination: Limit correction to 4-6 mmol/L per day 1, 4
  • Beer potomania: Discontinuing alcohol and providing adequate dietary sodium can dramatically improve hyponatremia 1

Common Pitfalls to Avoid

  • Never use fluid restriction as initial treatment for severe symptomatic hyponatremia—this is a medical emergency requiring hypertonic saline 1, 2
  • Never exceed 8 mmol/L correction in 24 hours in chronic or unknown-duration hyponatremia 1, 4
  • Never use fluid restriction in cerebral salt wasting—this worsens outcomes 1
  • Never ignore mild hyponatremia (130-135 mmol/L)—it increases fall risk (21% vs 5%) and mortality (60-fold increase with Na <130) 1, 2
  • Never use lactated Ringer's for hyponatremia treatment—it is hypotonic (130 mEq/L sodium) and worsens hyponatremia 1

References

Guideline

Management of Sodium Imbalance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Research

Diagnosis and management of hyponatraemia in hospitalised patients.

International journal of clinical practice, 2009

Research

Electrolytes: Sodium Disorders.

FP essentials, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.